U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07389408) titled 'A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict(R) Testing' on Jan. 15.
Brief Summary: The study is planned to observe and document the therapeutic decision-making process, treatment protocols, and clinical outcomes in patients with luminal breast cancer, whether they have undergone EndoPredict(R) testing or not
Study Start Date: April 01, 2025
Study Type: OBSERVATIONAL
Condition:
Breast Cancer
Breast Adenocarcinoma
Recruitment Status: RECRUITING
Sponsor: National and Kapodistrian University of Athens
Inf...